首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Translational andrology and urology

缩写:

ISSN:2223-4683

e-ISSN:2223-4691

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引3349
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Chenyu Han,Liuyang Miao,Yan Liu et al. Chenyu Han et al.
Background: The pronounced heterogeneity of bladder cancer (BLCA) drives divergent patient outcomes and therapy responses. Mitophagy, a pivotal cellular quality-control and metabolic mechanism, modulates the dynamics of t...
Arian Azarang,Virginie Papadopoulou,Kennita A Johnson et al. Arian Azarang et al.
This pilot study investigated the feasibility of contrast-enhanced ultrasound (CEUS) as a screening tool to identify kidney lesions in patients with rare genetic disorders predisposing them to kidney malignancies, aiming to reduce reliance ...
Xinguang Wang,Nian Zhang,Xin Liu et al. Xinguang Wang et al.
Background: Giant ureteral calculi are uncommon but pose significant management challenges. When associated with infection, they heighten the risk of urosepsis and complicate surgical planning, as conventional single-stag...
Haoming Hua,Zhe Tian,Jie Zhou et al. Haoming Hua et al.
Background: A balance between positive and negative regulation of the Toll-like receptor (TLR) signaling pathway is required to prevent harmful or inappropriate inflammatory responses. Although TLR9 has been reported to b...
Mark Xu,Alejandro Rodriguez,Ashok Hemal Mark Xu
Background and objective: Management of small renal masses has changed significantly since the concept of radical nephrectomy for kidney cancer was described in 1969. As improved imaging allowed the early detection of sma...
Weigang Ren,Jiaxiang Yi,Mingqiang Zeng et al. Weigang Ren et al.
Background: Cisplatin-based combination chemotherapy remains the cornerstone of treatment for advanced bladder cancer (BC). However, primary or acquired resistance following long-term use remains a critical unresolved iss...
Mohamad Abou Chakra,Amanda A Myers,Kathryn A Marchetti et al. Mohamad Abou Chakra et al.
Background: Intravesical Bacillus Calmette‑Guérin (BCG) has long been the standard therapy for high‑risk non‑muscle‑invasive bladder cancer (HR‑NMIBC), yet treatment response may vary with age. Sequential intravesic...